AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22512348 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (10 sessions, 20 minutes, 2 mA over 4 weeks)
Number of subjects: 13
Study 22512348 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (10 sessions, 20 minutes, 2 mA over 4 weeks)
Number of subjects: 13
Study 19846027 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat (80 mg or 120 mg daily)
Number of subjects: 0
Study 19846027 — intervention group
Group type: COMPARATOR
Intervention: Allopurinol (300/100 mg/day)
Number of subjects: 0
Study 19846027 — intervention group
Group type: EXPERIMENTAL
Intervention: Febuxostat
Number of subjects: 0
Study 19846027 — intervention group
Group type: COMPARATOR
Intervention: Allopurinol
Number of subjects: 0
Study 17464087 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone marrow cell (BMC) transplantation and GM-CSF administration (n = 17, 14 days post-injury)
Number of subjects: 35
Study 17464087 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone marrow cell (BMC) transplantation and GM-CSF administration (n = 6, between 14 days and 8 weeks post-injury)
Number of subjects: 35
Study 17464087 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone marrow cell (BMC) transplantation and GM-CSF administration (n = 12, more than 8 weeks post-injury)
Number of subjects: 35
Study 17464087 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 13) treated with conventional decompression and fusion surgery without BMC transplantation
Number of subjects: 35
Study 15044639 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy plus autologous stem-cell transplantation
Number of subjects: 197
Study 15044639 — intervention group
Group type: COMPARATOR
Intervention: CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone)
Number of subjects: 197
Study 15044639 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy plus autologous stem-cell transplantation (for high intermediate risk patients)
Number of subjects: 197
Study 15044639 — intervention group
Group type: COMPARATOR
Intervention: CHOP (for high intermediate risk patients)
Number of subjects: 197
Study 11449213 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral positioning (right and left 45 degrees lateral and supine)
Number of subjects: 12
Study 9018019 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine
Number of subjects: 30
Study 9018019 — intervention group
Group type: COMPARATOR
Intervention: Amantadine
Number of subjects: 30
Study 8519044 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg or 20 mg
Number of subjects: 217
Study 8519044 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg plus hydrochlorothiazide 25 mg
Number of subjects: 217
Study 8519044 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 10 mg
Number of subjects: 217
Study 3033339 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoxynol 9-impregnated contraceptive sponge
Number of subjects: 434
Study 3033339 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonusers of the sponge)
Number of subjects: 434
Study 31009802 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory cues during navigation
Number of subjects: 22
Study 31009802 — intervention group
Group type: COMPARATOR
Intervention: No auditory cues during navigation
Number of subjects: 22
Study 29107706 — intervention group
Group type: EXPERIMENTAL
Intervention: Body weight‐supported treadmill training (BWSTT) with real tDCS (1mA, 20min) on SMA
Number of subjects: 30
Study 29107706 — intervention group
Group type: COMPARATOR
Intervention: Body weight‐supported treadmill training (BWSTT) with sham stimulation
Number of subjects: 30
Study 27424661 — intervention group
Group type: EXPERIMENTAL
Intervention: unmodified fish oil TAG (uTAG)
Number of subjects: 29
Study 27424661 — intervention group
Group type: EXPERIMENTAL
Intervention: free fatty acids (FFA)
Number of subjects: 29
Study 27424661 — intervention group
Group type: COMPARATOR
Intervention: re-esterified TAG
Number of subjects: 29
Study 27424661 — intervention group
Group type: COMPARATOR
Intervention: ethyl esters (EE)
Number of subjects: 29
Study 25286015 — intervention group
Group type: EXPERIMENTAL
Intervention: Edaravone (MCI-186)
Number of subjects: 206
Study 25286015 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study 22573135 — intervention group
Group type: EXPERIMENTAL
Intervention: Total osteocalcin (OCN)
Number of subjects: 137
Study 22573135 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboxylated osteocalcin
Number of subjects: 137
Study 22573135 — intervention group
Group type: EXPERIMENTAL
Intervention: Under-carboxylated osteocalcin
Number of subjects: 137
Study 20722845 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary program of geriatric consultation, continuous rehabilitation, and discharge planning
Number of subjects: 162
Study 20722845 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 162
Study 19000191 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (ER:YAG laser ablation + 5FU application + NB-UVB therapy)
Number of subjects: 50
Study 19000191 — intervention group
Group type: COMPARATOR
Intervention: Mono-therapy (NB-UVB therapy only)
Number of subjects: 50
Study 19000191 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 50
Study 16640106 — intervention group
Group type: EXPERIMENTAL
Intervention: 3TC (4 mg/kg/day, max 100 mg) started simultaneously with IFN‐alpha2a for 6 months (group I)
Number of subjects: 177
Study 16640106 — intervention group
Group type: EXPERIMENTAL
Intervention: 3TC started 2 months prior to IFN‐alpha2a for 6 months (group II)
Number of subjects: 177
Study 16640106 — intervention group
Group type: COMPARATOR
Intervention: Both groups (I and II)
Number of subjects: 177
Study 12812880 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Small Incision Cataract Surgery (MSICS)
Number of subjects: 0
Study 12812880 — intervention group
Group type: COMPARATOR
Intervention: Extracapsular Cataract Extraction (ECCE)
Number of subjects: 0
Study 10638902 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 16
Study 10638902 — intervention group
Group type: COMPARATOR
Intervention: Diphenhydramine (control)
Number of subjects: 16
Study 8858404 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric-only leg extension DCER exercise (3-5 sets of 6 repetitions at 80% of one-repetition maximum load) for eight weeks
Number of subjects: 16
Study 8858404 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric-only leg extension DCER exercise
Number of subjects: 16
Study 8858404 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 16
Study 7679273 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone intervention for patients with osteoarthritis
Number of subjects: 0
Study 3440643 — intervention group
Group type: EXPERIMENTAL
Intervention: Microporous colestyramine (MPC) 9 g/day
Number of subjects: 18
Study 3440643 — intervention group
Group type: EXPERIMENTAL
Intervention: Microporous colestyramine (MPC) 12 g
Number of subjects: 18
Study 3440643 — intervention group
Group type: EXPERIMENTAL
Intervention: Microporous colestyramine (MPC) 18 g
Number of subjects: 18
Study 3440643 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 29802966 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized melanoma genomic risk information, genetic counselor phone call, educational booklet on melanoma prevention
Number of subjects: 892
Study 29802966 — intervention group
Group type: COMPARATOR
Intervention: Educational booklet on melanoma prevention
Number of subjects: 892
Study 26324284 — intervention group
Group type: EXPERIMENTAL
Intervention: Preemptive multimodal analgesic regimen (celecoxib, pregabalin, extended‐release oxycodone, and acetaminophen)
Number of subjects: 80
Study 26324284 — intervention group
Group type: COMPARATOR
Intervention: Intravenous morphine
Number of subjects: 80
Study 25182377 — intervention group
Group type: EXPERIMENTAL
Intervention: HF-NMES (75 Hz)
Number of subjects: 24
Study 25182377 — intervention group
Group type: EXPERIMENTAL
Intervention: LF-NMES (15 Hz)
Number of subjects: 24
Study 25182377 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 24
Study 25182377 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study 22131049 — intervention group
Group type: EXPERIMENTAL
Intervention: Gray-scale ultrasound (US) scoring system
Number of subjects: 62
Study 22131049 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Doppler ultrasound (PDUS) scoring system
Number of subjects: 62
Study 22131049 — intervention group
Group type: COMPARATOR
Intervention: Clinical indices
Number of subjects: 62
Study 22131049 — intervention group
Group type: EXPERIMENTAL
Intervention: Gray-scale US and PDUS
Number of subjects: 62
Study 22131049 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified scoring system referring to gray-scale US and PDUS findings
Number of subjects: 62
Study 17894152 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender aromatherapy
Number of subjects: 54
Study 17894152 — intervention group
Group type: COMPARATOR
Intervention: Placebo (nonscented baby oil)
Number of subjects: 54
Study 15645698 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin dosage calculation device (IDC)
Number of subjects: 83
Study 15645698 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional methods)
Number of subjects: 83
Study 15645698 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups combined (months 6-12)
Number of subjects: 83
Study 15645698 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 83
Study 12503831 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/day)
Number of subjects: 12
Study 12503831 — intervention group
Group type: EXPERIMENTAL
Intervention: Dothiepin (75 mg/day for 1 week followed by 150 mg/day for 4 weeks)
Number of subjects: 12
Study 12503831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 9692699 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 10 mg o.m.
Number of subjects: 156
Study 9692699 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine 800 mg nocte
Number of subjects: 156
Study 7937784 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-1-infected persons
Number of subjects: 0
Study 7937784 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhesus macaques infected with pathogenic strain of SIV
Number of subjects: 0
Study 7937784 — intervention group
Group type: COMPARATOR
Intervention: SIV-infected African green monkeys
Number of subjects: 0
Study 2895761 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.5 mg
Number of subjects: 0
Study 2895761 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam 30 mg
Number of subjects: 0
Study 2895761 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29535280 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy (inhalation of aroma oil blended with lavender, ylang-ylang, and neroli at a ratio of 4:2:1, twice before and after CAG)
Number of subjects: 64
Study 29535280 — intervention group
Group type: COMPARATOR
Intervention: Control group (no aromatherapy)
Number of subjects: 64
Study 26785764 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART)
Number of subjects: 1815
Study 26232144 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention (active observation and resolution of breastfeeding problems)
Number of subjects: 100
Study 26232144 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 100
Study 23725162 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter arterial chemoembolization (TACE)
Number of subjects: 418
Study 23725162 — intervention group
Group type: COMPARATOR
Intervention: Transcatheter arterial infusion (TAI)
Number of subjects: 418
Study 23725162 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter arterial embolization (TAE)
Number of subjects: 418
Study 20605308 — intervention group
Group type: EXPERIMENTAL
Intervention: Implants with platform switching (test)
Number of subjects: 4
Study 20605308 — intervention group
Group type: COMPARATOR
Intervention: Control implants with horizontally matching implant-abutment connection (control)
Number of subjects: 4
Study 20605308 — intervention group
Group type: COMPARATOR
Intervention: Comparison between test and control implants
Number of subjects: 4
Study 18206919 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg bremelanotide as an intranasal spray
Number of subjects: 342
Study 18206919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 342
Study 16391889 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Doppler ultrasonography (PDU)
Number of subjects: 41
Study 16391889 — intervention group
Group type: COMPARATOR
Intervention: Nailfold capillaroscopy (NFC)
Number of subjects: 41
Study 14666019 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic bubble trap (group 1)
Number of subjects: 50
Study 14666019 — intervention group
Group type: COMPARATOR
Intervention: Placebo dynamic bubble trap (group 2)
Number of subjects: 50
Study 11104110 — intervention group
Group type: COMPARATOR
Intervention: 0 mg nicotine gum
Number of subjects: 30
Study 11104110 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg nicotine gum
Number of subjects: 30
Study 11104110 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg nicotine gum
Number of subjects: 30
Study 8625682 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone loading dose of 25 micrograms/kg (LOW) followed by infusion of 0.5 microgram/kg/min
Number of subjects: 24
Study 8625682 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone loading dose of 50 micrograms/kg (MED) followed by infusion of 0.5 microgram/kg/min
Number of subjects: 24
Study 8625682 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone loading dose of 75 micrograms/kg (HIGH) followed by infusion of 0.5 microgram/kg/min
Number of subjects: 24
Study 8625682 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone administration (all doses)
Number of subjects: 24
Study 1524334 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance directive (California Durable Power of Attorney)
Number of subjects: 204
Study 1524334 — intervention group
Group type: COMPARATOR
Intervention: Control group (no advance directive offered)
Number of subjects: 204
Study 6489414 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride (novel enterokinetic agent)
Number of subjects: 16
Study 6489414 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 30708075 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous adrenaline
Number of subjects: 170
Study 30708075 — intervention group
Group type: COMPARATOR
Intervention: Advanced life support (ALS)
Number of subjects: 170
Study 28941281 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass-ionomer cement (GIC)
Number of subjects: 100
Study 28941281 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc polycarboxylate cement (ZPC)
Number of subjects: 100
Study 28941281 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-cured resin composite (DCRC)
Number of subjects: 100
Study 28941281 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 100
Study 28941281 — intervention group
Group type: COMPARATOR
Intervention: Prepared but unrestored (control)
Number of subjects: 100
Study 26822542 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness inducing intervention (15 minutes)
Number of subjects: 309
Study 26822542 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness (correlational study)
Number of subjects: 309
Study 25045257 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisphosphonates (risedronate 35 mg weekly) for 12 months
Number of subjects: 79
Study 25045257 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisphosphonates along with nutritional supplementation (40 g protein, 600 kcal daily) for the first 6 months
Number of subjects: 79
Study 25045257 — intervention group
Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 79
Study 22278377 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential intravenous 5‐FU at 800 mg/m2 for 5 days every 4 weeks followed by weekly PTX at 80 mg/m2
Number of subjects: 161
Study 22278377 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential S‐1 at 80 mg/m2 for 4 weeks and 2-week rest followed by PTX
Number of subjects: 161
Study 22278377 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent intravenous 5‐FU at 600 mg/m2 for 5 days and weekly PTX at 80 mg/m2 every 4 weeks
Number of subjects: 161
Study 22278377 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent S‐1 for 14 days and PTX at 50 mg/m2 on days 1 and 8 every 3 weeks
Number of subjects: 161
Study 20588130 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery audiotape intervention
Number of subjects: 56
Study 20588130 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 56
Study 20588130 — intervention group
Group type: COMPARATOR
Intervention: Standard care control
Number of subjects: 56
Study 17635557 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacosamide 200 mg/day
Number of subjects: 418
Study 17635557 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacosamide 400 mg/day
Number of subjects: 418
Study 17635557 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacosamide 600 mg/day
Number of subjects: 418
Study 17635557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 418
Study 16275232 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl E2 plus cyproterone acetate (0.01 mg + 3 mg/day)
Number of subjects: 90
Study 16275232 — intervention group
Group type: COMPARATOR
Intervention: Norethindrone acetate (2.5 mg/day)
Number of subjects: 90
Study 16275232 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl E2 plus cyproterone acetate
Number of subjects: 90
Study 16275232 — intervention group
Group type: COMPARATOR
Intervention: Norethindrone acetate
Number of subjects: 90
Study 12109557 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually adjusted footwear with good shock absorbing properties (test group)
Number of subjects: 176
Study 12109557 — intervention group
Group type: COMPARATOR
Intervention: Subjects' own, used footwear (control group)
Number of subjects: 176
Study 12109557 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually adjusted footwear (test group)
Number of subjects: 176
Study 12109557 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 176
Study 9974195 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training for 2 months, 30 min sessions, 4 times a week
Number of subjects: 20
Study 9974195 — intervention group
Group type: COMPARATOR
Intervention: Control group (no aerobic training)
Number of subjects: 20
Study 7755224 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg/d of ursodeoxycholic acid
Number of subjects: 1004
Study 7755224 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg/d of ursodeoxycholic acid
Number of subjects: 1004
Study 7755224 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 mg/d of ursodeoxycholic acid
Number of subjects: 1004
Study 7755224 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1004
Study 2097894 — intervention group
Group type: EXPERIMENTAL
Intervention: Biologically standardized extract of mites (active therapy)
Number of subjects: 58
Study 2097894 — intervention group
Group type: COMPARATOR
Intervention: Saline buffered solution (placebo)
Number of subjects: 58
Study 6775548 — intervention group
Group type: EXPERIMENTAL
Intervention: nasogastric saline solution alone
Number of subjects: 62
Study 6775548 — intervention group
Group type: EXPERIMENTAL
Intervention: nasogastric saline irrigation with oral mannitol
Number of subjects: 62
Study 6775548 — intervention group
Group type: EXPERIMENTAL
Intervention: oral mannitol solution without saline
Number of subjects: 62
Study 31549889 — intervention group
Group type: EXPERIMENTAL
Intervention: Venetoclax 400 mg daily plus rituximab
Number of subjects: 0
Study 31549889 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 30389818 — intervention group
Group type: EXPERIMENTAL
Intervention: Forward-leaning bikerlike position
Number of subjects: 80
Study 27090392 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated F2-isoprostanes
Number of subjects: 78
Study 27090392 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV parameters (SDNN, VLF, LF, total power)
Number of subjects: 78
Study 27090392 — intervention group
Group type: EXPERIMENTAL
Intervention: F2-isoprostanes
Number of subjects: 78
Study 26556080 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (cycling training at 70% of maximal intensity for 40 min/d, 3 d/wk for 3 months)
Number of subjects: 50
Study 26556080 — intervention group
Group type: COMPARATOR
Intervention: Control group (health education)
Number of subjects: 50
Study 23684438 — intervention group
Group type: EXPERIMENTAL
Intervention: 13 g ground flaxseed
Number of subjects: 25
Study 21566232 — intervention group
Group type: EXPERIMENTAL
Intervention: NeuroFlo treatment
Number of subjects: 515
Study 21566232 — intervention group
Group type: COMPARATOR
Intervention: Standard medical management (control)
Number of subjects: 515
Study 19703665 — intervention group
Group type: EXPERIMENTAL
Intervention: NanoGreens vegetable supplement drink for 90 days
Number of subjects: 40
Study 19703665 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study 16776704 — intervention group
Group type: EXPERIMENTAL
Intervention: Rizatriptan plus trimebutine (10 mg rizatriptan + 200 mg trimebutine)
Number of subjects: 40
Study 16776704 — intervention group
Group type: COMPARATOR
Intervention: Rizatriptan alone
Number of subjects: 40
Study 15359672 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory condition
Number of subjects: 0
Study 15359672 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual condition
Number of subjects: 0
Study 15359672 — intervention group
Group type: COMPARATOR
Intervention: Both conditions
Number of subjects: 0
Study 10671921 — intervention group
Group type: EXPERIMENTAL
Intervention: Axillary node clearance
Number of subjects: 466
Study 10671921 — intervention group
Group type: COMPARATOR
Intervention: Axillary node sample
Number of subjects: 466
Study 10671921 — intervention group
Group type: EXPERIMENTAL
Intervention: Axillary node sample with radiotherapy
Number of subjects: 466